Related by context. All words. (Click for frequent words.) 73 humanized antibody 73 A3 adenosine receptor 72 chimeric monoclonal antibody 72 HuLuc# 72 humanized monoclonal antibody 72 bispecific 71 antibody MAb 71 Sym# 70 tumor antigen 70 somatostatin receptors 70 VEGF receptor 70 vinca alkaloid 70 IMA# 70 humanised antibody 69 anti CD3 69 targeted antifolate 69 angiogenesis inhibition 69 chemokine receptor 69 CCR9 69 EGF receptor 69 tyrosine kinase receptor 69 ENMD # 69 ErbB3 69 VitiGam 69 investigational humanized monoclonal antibody 69 uricase 69 EGFr 69 Squalamine 69 HuMax EGFr 68 drug conjugate 68 antibody fragment 68 effector function 68 targeting CD# 68 anti EGFR antibody 68 humanized monoclonal 68 Factor Receptor 68 HCV protease 68 depsipeptide 68 mTOR mammalian target 68 HDACi 68 humanized monoclonal antibodies 68 orally bioavailable 68 Tarvacin 68 Nanobody 68 erlotinib Tarceva ® 68 B lymphocyte stimulator 68 human monoclonal antibody 68 selective inhibition 68 NPC 1C 68 intratumoral injection 68 oral prodrug 67 HER2 receptor 67 CYT# potent vascular disrupting 67 potent cytotoxic 67 diarrhea predominant irritable 67 protein tyrosine phosphatase 1B 67 EpCAM 67 vascular disrupting agents 67 Tyrima 67 monoclonal antibody mAb 67 BiTE 67 pharmacological chaperone 67 antiproliferative effects 67 HQK 67 pathophysiological effects 67 Aviptadil 67 multi kinase inhibitor 67 interleukin IL -# 67 PTP 1B 67 JAK3 67 ADAMTS# 67 Gleevec resistant 67 JAK inhibitors 67 proteasome inhibitor 67 IgG1 67 Angiolix 67 HyACT 67 PSMA ADC 67 IGFBP2 67 JAK2 inhibitor 67 DNA intercalator 67 soluble tumor necrosis 67 liposomal formulation 67 T#I [002] 67 selective kinase inhibitor 67 CCX# 67 AEG# 67 PDE4 inhibitor 67 immunomodulator 67 mertansine 67 S#P# 67 vascular disrupting agent 67 accumulate preferentially 67 siRNA therapeutic 67 LHRH antagonists 67 targeted radiotherapeutic 67 gefitinib Iressa 67 CEQ# 67 murine monoclonal antibody 67 Protein Kinase C 67 NTDDS 67 Imprime PGG 67 MGd 67 POTELLIGENT ® 67 Xanafide 67 Galectin 67 GW# [003] 66 MEK inhibitor 66 Pertuzumab 66 angiogenesis inhibitor 66 JAK#/JAK# 66 XmAb# 66 thymidylate synthase TS 66 surface glycoprotein 66 TRAIL R2 66 NKG2D 66 RAV# 66 TLE3 66 PDGF receptor 66 NSCLC tumors 66 peptide antigens 66 bispecific antibody 66 pertuzumab 66 MKC# MKC# PP 66 Vandetanib 66 CD# monoclonal antibody 66 Epstein Barr Virus EBV 66 MORAb 66 Alfacell proprietary ribonuclease 66 delipidation 66 therapeutic monoclonal antibody 66 vWF 66 poly ADP ribose polymerase 66 USP# 66 Symadex 66 CRTH2 66 mGlu2 3 66 phosphate S1P 66 TG# [003] 66 Tarvacin TM 66 preclinically 66 M2 subunit 66 Janus kinase 66 Aplidin R 66 apoptotic pathway 66 5 HT4 receptor 66 uPA 66 Xencor XmAb 66 IMC #B 66 novel peptide 66 Belimumab 66 potent antiproliferative 66 Lyn kinase 66 murine mouse 66 P#X# 66 TLR9 agonist 66 nucleoside analog 66 cilengitide 66 Tumor Necrosis Factor 66 antitumoral 66 CCR2 66 polyclonal antibody 66 Vidofludimus 66 Talabostat 66 sodium glucose cotransporter 66 MAb 66 JAK1 66 antisense oligonucleotide 66 kidney urologic 66 HER2 antibody 66 peptide conjugated 66 FGFR 66 Trastuzumab 66 Interferon beta 66 Dapagliflozin 66 ZFP TF 66 immunostimulatory 66 DAVANAT 66 Virulizin ® 65 tumor specific antigen 65 Archexin 65 proteasome inhibitor bortezomib 65 HepDirect prodrug 65 integrin receptors 65 alpha#beta# 65 synthetic peptide 65 AT1R 65 CanAg 65 c MET 65 Liposomal 65 Factor VIIa 65 recombinant fusion 65 Blinatumomab 65 engineered RAP peptides 65 Aurora kinase 65 PI3K/mTOR 65 IL #E 65 PARP inhibition 65 CCR9 antagonist 65 Hsp# Inhibitor 65 TLR8 65 selective modulator 65 Olaparib 65 orally administered inhibitor 65 Fleximer 65 BAL# [001] 65 tyrosine kinase inhibitor 65 HSP# inhibitor 65 Nedd4 65 histone deacetylase 65 mda 7 65 bevacizumab Avastin ® 65 immatics 65 NXL# 65 oncolytic 65 Mucosal 65 Curaxin 65 oncolytic virus 65 immune modulating 65 taxane derivative 65 ALN TTR 65 specific lectin receptors 65 Aflibercept 65 thalidomide Thalomid 65 SIRT2 65 monoclonal antibody MAb 65 non nucleoside 65 cetuximab Erbitux ® 65 TRAIL induced apoptosis 65 androgen receptor AR 65 Ii protein 65 adenoviral 65 molecularly targeted 65 YONDELIS 65 immune stimulatory 65 SSc 65 castrate resistant prostate cancer 65 Onconase 65 Azedra 65 hypoxia inducible factor 65 chimeric antibodies 65 somatostatin analogue 65 Fc receptor 65 anti angiogenic agent 65 Anticalin ® 65 synthetic retinoid 65 receptors PPARs 65 receptor tyrosine kinase inhibitor 65 antisense inhibitors 65 humanised monoclonal antibody 65 FLT3 65 Corgentin 65 SGLT2 inhibitors 65 enkephalin 65 IRX 2 65 TNF receptors 65 M1 muscarinic 65 Bavituximab 65 Fibroblast Growth Factor Receptor 65 colon carcinoma 65 monoclonal anti 65 TNF Tumor Necrosis Factor 65 novel VDA molecule 65 Proxinium TM 65 Omacetaxine 65 personalized immunotherapy 65 CXCR4 receptor 65 Hsp# inhibition 65 kinase inhibition 65 IMC A# 65 antiangiogenic 65 CD# molecule 65 TNFR 65 HDAC enzymes 65 tubulin polymerization 65 radiolabeled monoclonal antibody 65 Lpathomab 65 histone deacetylase HDAC 65 glycopeptide 65 MUC1 65 AAG geldanamycin analog 65 ErbB 65 Angiocept 65 proteasome inhibitors 65 therapeutic monoclonal antibodies 65 MEK ERK 65 lysophosphatidic acid LPA 64 paclitaxel Taxol 64 PEGylated 64 Vidaza azacitidine 64 pan HDAC inhibitor 64 Pancreate 64 FK# 64 DiLA2 64 Carfilzomib 64 EGFR HER 64 histone deacetylase inhibitor 64 DepoVax 64 immunomodulation 64 Palifosfamide 64 novel immunotherapeutic 64 Nanobodies 64 HIF 1a 64 PSMA antibody 64 IgG1 monoclonal antibody 64 rhIL 7 64 Tarvacin Anti Viral 64 IAP inhibitor 64 Eg5 64 PKC# 64 lymphotoxin 64 replicon 64 Traficet EN 64 hypereosinophilic syndrome 64 Enzastaurin 64 CBLC# 64 investigational immunotherapy 64 deacetylase inhibitors 64 SGLT2 64 HuMax 64 chemically modified siRNA 64 Transdrug ® nanoparticle 64 IGF1R 64 antisense inhibitor 64 NF kappaB activation 64 MEK inhibitors 64 trabectedin 64 RANK Ligand 64 relapsing multiple sclerosis 64 trastuzumab Herceptin 64 DermaVir 64 Ocrelizumab 64 anti fibrotic 64 humanized anti 64 Fas ligand 64 androgen independent 64 AVI NEUGENE 64 sunitinib Sutent ® 64 ERK signaling 64 flavopiridol 64 Cytochrome P# 64 5 HT6 receptor 64 CD# receptor 64 Omacetaxine mepesuccinate 64 HuMax HepC 64 THR beta agonist 64 Anticalin R 64 Fc gamma receptor 64 immune modulatory 64 radionuclide therapy 64 alpha folate receptor 64 cMET 64 modulator SERM 64 aT cell 64 C5aR 64 RNAi therapeutic targeting 64 mTOR kinase 64 immunomodulatory 64 induce apoptosis 64 protein tyrosine phosphatase 64 PRTX 64 Amplimexon 64 bortezomib Velcade 64 vorinostat 64 BZL# 64 immunomodulating 64 Tumour Vascular Disrupting Agent 64 myelofibrosis polycythemia vera 64 MMP9 64 farletuzumab 64 murine models 64 human IgG1 monoclonal 64 Zalypsis 64 Chemokine Receptor 64 selective agonist 64 trastuzumab Herceptin ® 64 Aplidin 64 Anticalins ® 64 selective antagonist 64 mGluR2 NAM 64 Pradefovir 64 virosome 64 HGS# 64 serine protease 64 bioactive lipids 64 EGFR tyrosine kinase inhibitors 64 CDDO Im 64 MAGE A3 ASCI 64 Imatinib mesylate 64 huC# DM4 64 hepatoma 64 induces apoptosis 64 anticancer therapies 64 vitro assay 64 immunotherapeutic agent 64 AtuRNAi 64 receptor tyrosine kinase 64 Elotuzumab 64 drug zotarolimus 64 Temsirolimus 64 PARP inhibitor 64 novel immunomodulatory 64 peptidomimetic 64 selective adenosine 64 antiapoptotic 64 potent anticancer 64 acid phosphatase PAP 64 IMiDs R 64 Ustekinumab 64 sCD# 64 Quinamed 64 Th1 type 64 cyclin dependent kinase 64 glycosylated 64 volociximab 64 novel topoisomerase 64 G Protein Coupled 64 apoptosis proteins 64 TNFa 64 cetuximab Erbitux R 64 cytoprotective 64 peptibody 64 ATTR 64 RNA antagonist 64 Gefitinib 64 R roscovitine 64 delta isoform 64 Sapacitabine 64 investigational antibody 64 Panzem R 64 tanespimycin 64 virus AAV 64 Micromet BiTE 64 receptor CD# 64 mAb 64 Irinotecan 64 monocytes macrophages 64 vitro cytotoxicity 63 PEGylated Fab fragment 63 anti amnesic 63 alefacept 63 Cannabinor 63 INCB# [001] 63 irreversible inhibitor 63 Aptamer 63 Vicinium TM 63 p# biomarker 63 proprietary polysaccharide 63 favorable pharmacokinetic profile 63 cell adhesion molecule 63 lymphoid cells 63 experimental autoimmune encephalomyelitis 63 PI3K Akt 63 Epidermal Growth Factor Receptor 63 Apaziquone 63 Multimeric 63 erlotinib Tarceva 63 protein kinase inhibitor 63 #HT#A 63 TNF alpha selectively neutralizing 63 obatoclax 63 CTLA 4 63 CARBOSOME TM formation 63 GMX# 63 PEGylated interferon 63 BRAF kinase 63 imatinib Gleevec ® 63 MET amplification 63 demonstrated antitumor activity 63 LPA1 63 MT#/MEDI-# 63 CD#b 63 binds selectively 63 Fc fusion protein 63 Ceflatonin 63 Sphingomab 63 catenin 63 CDK inhibitor 63 GV# [001] 63 cytotoxic T lymphocyte 63 OHR/AVR# 63 PDGFR 63 IAP inhibitors 63 PROCHYMAL 63 immunotoxin 63 Factor VEGF 63 GPNMB 63 serine threonine kinase 63 metaglidasen 63 Psoriatic arthritis 63 gastrin 63 oncolytic vaccine 63 γ secretase 63 NEUGENE 63 HER3 63 incretin 63 antisense drug 63 receptor molecule 63 potent anti angiogenic 63 Cyclosert 63 TNF α 63 polysaccharide polymer 63 Pralatrexate 63 SGLT 63 erythropoietic 63 Elesclomol 63 sd rxRNA 63 paclitaxel poliglumex 63 antiproliferative activity 63 cisplatin resistant 63 inhibits protein synthesis 63 antisense inhibition 63 Janus Kinase 63 Litx 63 Oral NKTR 63 HER2 HER3 63 Aliskiren 63 dasatinib Sprycel 63 Nanobody ® 63 liposomal delivery 63 HGS ETR2 63 UsiRNAs 63 Smac mimetics 63 ZK EPO 63 OXi# 63 luteinizing hormone releasing 63 recombinant polyclonal antibody 63 extracellular domain 63 NFkB 63 histone deacetylase HDAC inhibitors 63 Upregulation 63 chemoresistance 63 ERK1 2 63 TRAIL receptor 63 cleavable linker 63 mTOR inhibitor 63 docetaxel Taxotere R 63 EGFR inhibitors 63 bortezomib Velcade ® 63 small molecule agonists 63 thrombin receptor 63 Trp p8 63 retinoic acid receptor 63 deacetylation 63 VAPRISOL 63 trans retinoic acid 63 antibody MT# 63 CTAP# Capsules 63 prostanoid 63 PORxin TM 63 fluoropyrimidine 63 cellular immunotherapy 63 SERMs 63 Locked Nucleic Acid LNA 63 NS4A 63 Wnt signaling pathway 63 Nicotinic 63 Bruton tyrosine kinase Btk 63 OMNARIS HFA 63 HER1 63 YONDELIS R 63 oxidative stress inducer 63 investigational monoclonal antibody 63 GPx 63 selective orally bioavailable 63 antiangiogenic agent 63 XmAb 63 ANG# 63 Interferon alpha 63 interferon γ 63 MMAE 63 Lenocta 63 GeneICE 63 bevacizumab Avastin R 63 Sphingomab TM 63 cutaneous T 63 attach auristatin 63 VSV G 63 potent inhibitor 63 potent inhibition 63 Kahalalide F 63 monoclonal 63 IMP# 63 acetylcholinesterase AChE 63 MTP inhibitor 63 ARRY # 63 JAK inhibitor 63 ligand TRAIL 63 peripherally acting 63 neurotrophic 63 liposomal doxorubicin 63 hormone gastrin 63 Bafetinib 63 antitumor effects 63 oncoproteins 63 Lenalidomide 63 PC# cells 63 E#F# 63 colorectal carcinoma 63 NY ESO 63 nicotinic alpha 7 63 carbohydrate polymer 63 HCD# [002] 63 immunoconjugate 63 COX2 63 OMP #M# 63 monoclonal antibody 63 sorafenib Nexavar 63 EGFR HER2 63 leukotriene pathway 63 myeloproliferative disorders 63 Locked Nucleic Acid 63 CIMZIA TM 63 mu opioid receptor antagonist 63 telomerase reverse transcriptase 63 PKC enzyme 63 syngeneic 63 TriRima 63 Epratuzumab 63 annexin 63 activin 63 Scancell 63 galectins 63 docetaxel Taxotere ® 63 OncoVEX GM CSF 63 adenoviral vectors 63 ADP receptor antagonist 63 Immunohistochemical analysis 63 TGF beta1 63 mGluR5 antagonist 63 Clusterin 63 folate receptor 63 CD#L 63 adaptive immunity 63 entinostat 62 oncoprotein 62 BRAF inhibitors 62 transmembrane protein 62 isotype 62 glycosyltransferase 62 isoform selective 62 TGF Beta 62 aurora kinase 62 Cardiotoxicity 62 phosphatidylinositol 3 62 factor Xa 62 gastrointestinal stromal tumors GISTs 62 Enkephalin 62 IMiDs ® compound 62 glioma cells 62 cathepsins 62 DCVax R 62 tyrosine kinase inhibitors 62 anti CD3 antibody 62 thymalfasin 62 Guanilib 62 HuMax TAC 62 familial amyloidotic polyneuropathy FAP 62 mediated apoptosis 62 MAGE A3 62 Seliciclib 62 exon skipping 62 metastatic malignant 62 TTR gene 62 selectively binds 62 dasatinib Sprycel ® 62 CXCR7 62 eIF 4E 62 immunotherapeutic vaccine 62 Safinamide 62 CA4P 62 nucleoside analogues 62 ATL# [001] 62 demethylating agent 62 alpha interferon 62 C5a 62 potent topoisomerase II 62 CD# antibody [001] 62 PD LID 62 Beta catenin pathway 62 activin receptor type 62 Kinase Inhibitor 62 cyclin dependent kinase inhibitor 62 recombinant albumin 62 Fludara ® 62 p# inhibitor 62 reslizumab 62 bifunctional 62 developing TB4 62 Tyrosine Kinase Inhibitor 62 AAV2 62 Sudhir Agrawal D.Phil 62 LY# [002] 62 TLR7 62 Tarmogen 62 pegylated liposomal doxorubicin 62 Abatacept 62 ESBA# 62 multikinase inhibitor 62 gene inactivation 62 partial agonist 62 Cdc7 62 costimulation 62 CIMZIA ™ 62 glucagon receptor 62 MAP kinase 62 ART# 62 SYN# 62 PNP inhibitor 62 cathepsin K inhibitor 62 Hemopurifier ® 62 azacytidine 62 Aurora Kinase 62 DermaVir Patch 62 pancreatic adenocarcinoma 62 antisense oligonucleotides 62 anticancer compound 62 IGF 1R 62 INS# [001] 62 thyroid hormone receptor 62 PEGylated anti 62 Survivin 62 PrevOnco ™ 62 antibody cytokine 62 TRX1 62 ErbB2 positive 62 PPARgamma 62 cannabinor 62 chimeric antibody 62 antagomirs 62 CORT # 62 L asparaginase 62 prophylactic vaccine 62 OvaRex MAb 62 TLR3 62 imatinib Gleevec 62 SAR# [002] 62 HGS ETR1 mapatumumab 62 vanilloid receptor 62 Methylnaltrexone 62 fosbretabulin 62 antiangiogenic therapy 62 p# mitogen activated 62 Insegia 62 DOS# 62 recurrent glioblastoma multiforme 62 small molecule activators 62 GRP# 62 HTRF 62 Intravenous CP 62 ribonucleotide reductase clinically validated 62 rxRNA 62 RAF kinase 62 #T# L1 62 ZOLINZA 62 HCV protease inhibitors 62 recombinant adeno associated 62 pDCs 62 PEG SN# 62 Pentraxin 2 62 TPI ASM8 62 PI3 kinase 62 Alocrest 62 Akt activation 62 MET VEGFR2 62 phosphorylate 62 hepatitis C viral infection 62 TLR antagonist 62 LHRH 62 thrombopoietin 62 Zolinza 62 orally dosed 62 alpha#beta# integrin 62 PKC isoforms 62 immunoregulation 62 IMiDs ® 62 glycosylation profile 62 Qdot 62 Resten NG 62 Mesothelin 62 Imprime PGG ® 62 Cloretazine 62 prodrug 62 VA# [002] 62 TACI Ig 62 vidofludimus 62 costimulatory molecules 62 HTS assay 62 Anticalin 62 CD4 monoclonal antibody 62 Pathway Inhibitor 62 trastuzumab Herceptin R 62 Ofatumumab 62 FGFR2 62 CTLs 62 ASC J9 62 Anticalins R 62 APOPTONE 62 Davanat 62 metastatic neuroendocrine tumors 62 anti CTLA 62 histone deacetylase inhibitors 62 lexidronam injection 62 lentiviral vector 62 bispecific antibodies 62 HER2 ErbB2 62 investigational therapies 62 MAPK pathway 62 juvenile chondrocytes 62 fusion protein 62 CD# antigen 62 bleomycin 62 miR #a [002] 62 proto oncogene 62 selective inhibitor 62 Campath ® 62 NS#/#A protease 62 DepoVax TM 62 prodrugs 62 chemokine 62 Zorbtive TM 62 TRO# 62 renal fibrosis 62 rxRNA ™ compounds 62 naturally occurring molecule 62 Cyclosert TM 62 immunomodulatory properties 62 sunitinib malate 62 cancer immunotherapies 62 novel anticancer 62 AKT inhibitor 62 LB# [003] 62 homodimers 62 PNT# 62 synthetic siRNA 62 BCR ABL inhibitors 62 Fenretinide 62 anticancer therapeutics 62 Cutaneous T 62 human antibody therapeutics 62 Dendritic cell 62 Glufosfamide 62 FGFR3 62 Lymphoid 62 WT1 62 proteoglycan 62 HDAC6 62 resolvins 62 pro angiogenic 62 histone deacetylases 62 soluble receptor 62 herpes simplex viruses 62 immune modulator 62 Lixivaptan 62 Tissue Factor 62 Bortezomib 62 Curaxins 62 LEX System 62 monoclonal antibodies MAbs 62 ADAM# 62 rhITF 62 virotherapy 62 hA# 62 intercellular signaling 62 cAMP signaling 62 tumor vasculature 62 isotypes 62 beta 1a 62 antitumor 62 gemcitabine Gemzar 62 OMP #R# 62 fast skeletal troponin 62 MDRNA proprietary 62 CD# CD# 62 selectively inhibits 62 hCG beta 62 related apoptosis inducing 62 avidin 62 antimitotic 62 IL #R 62 Romidepsin 62 vitro pharmacology 62 targets Galectin receptors 62 pediatric acute lymphoblastic 62 HDAC Inhibitor 62 Estrogen Receptor 62 BRAF mutation 62 TNFα 62 gastric adenocarcinoma 62 Luteinizing Hormone Releasing Hormone 62 Angiotensin II 62 highly selective endothelin 62 tubulin inhibitor 62 Exherin TM 62 iRGD 62 darinaparsin ZIO 62 BRAF inhibitor 62 Six3 62 histone deacetylase HDAC inhibitor 62 Phase #b/#a clinical 62 mutational status 62 Taxol ® 62 TLR agonists 62 EphA2 62 SPC# [001] 62 MT# MEDI 62 Solazed ™ 62 glioblastoma multiforme GBM 62 FAAH 62 CD1d 62 midkine 62 HER2/neu 62 LHRH receptor positive 62 FGFR4 62 retinoid X 62 novel prodrug 62 DXL TM 61 Panzem R NCD 61 Zysolin TM 61 tubulin binding 61 ZFN modified 61 biologic therapeutics 61 anti CD3 monoclonal 61 Transfection Reagent 61 M2e 61 TGF alpha 61 cellular cytotoxicity 61 ActA 61 CRAC channel 61 QbG# 61 ALV# 61 polymerase inhibitors 61 adipogenic 61 Bendavia 61 TLK# 61 MetMAb 61 evaluating tivozanib 61 TÎ ² 4 61 A2A receptor 61 Kinases 61 enzyme inhibitors 61 small molecule thrombopoietin 61 polymerase inhibitor 61 biomarker assays 61 alkylating 61 AFFiRiS 61 murine model 61 Pemetrexed 61 CD# antibodies 61 serine proteases 61 Factor NGF 61 VEGFR2 61 constipation OIC 61 Anavex #-# 61 Trofex 61 Pharmacokinetics PK 61 neuropilin 61 galectin 61 EGFR pathway 61 LymphoStat B TM 61 transgene expression 61 acadesine 61 Teplizumab 61 CCR1 61 Mutational 61 metalloprotease 61 nicotinic acetylcholine receptor 61 CYC# 61 antibody mediated 61 alkylating agent 61 gamma secretase inhibitors 61 CD# expressing 61 BHT DNA 61 BRIM2 61 cytotoxin 61 denileukin diftitox 61 oral JAK1 61 neratinib 61 MEK1 61 recombinant antibodies 61 protein tyrosine phosphatases 61 hormone agonist 61 ON #.Na 61 immunoregulatory 61 clinically validated targets 61 PDE4 61 OXIGON 61 PKCi 61 colony stimulating factor 61 NS5A 61 HyperAcute 61 cytotoxic T 61 TGF ß 61 HDAC inhibition 61 Bleomycin 61 DUROS 61 adult mesenchymal stem 61 TLR9 agonists 61 Dendritic Cell